Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

77 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy of the combination of cisplatin with either gemcitabine and vinorelbine or gemcitabine and paclitaxel in the treatment of locally advanced or metastatic non-small-cell lung cancer: a phase III randomised trial of the Southern Italy Cooperative Oncology Group (SICOG 0101).
Comella P, Filippelli G, De Cataldis G, Massidda B, Frasci G, Maiorino L, Putzu C, Mancarella S, Palmeri S, Cioffi R, Roselli M, Buzzi F, Milia V, Gambardella A, Natale D, Bianco M, Ghiani M, Masullo P; Southern Italy Cooperative Oncology Group. Comella P, et al. Among authors: frasci g. Ann Oncol. 2007 Feb;18(2):324-30. doi: 10.1093/annonc/mdl396. Epub 2006 Oct 27. Ann Oncol. 2007. PMID: 17071935 Free article. Clinical Trial.
Weekly dose-dense cisplatin-epirubicin-paclitaxel administration with granulocyte colony-stimulating factor support does not substantially improve prognosis in extensive disease small-cell lung cancer. A SICOG phase II study.
Frasci G, Comella P, Carreca I, DeCataldis G, Muci D, Brunetti C, Russo A, Palmeri S, D'Aniello R, Giordano R, D'Aiuto M, Comella G; Southern Italy Cooperative Oncology Group. Frasci G, et al. Oncology. 2005;68(2-3):223-9. doi: 10.1159/000086778. Epub 2005 Jul 7. Oncology. 2005. PMID: 16015038 Clinical Trial.
Comparison of the safety and efficacy of paclitaxel plus gemcitabine combination in young and elderly patients with locally advanced or metastatic non-small cell lung cancer. A retrospective analysis of the Southern Italy Cooperative Oncology Group trials.
Comella P, Gambardella A, Frasci G, Avallone A, Costanzo R; SICOG investigators. Comella P, et al. Among authors: frasci g. Crit Rev Oncol Hematol. 2008 Feb;65(2):164-71. doi: 10.1016/j.critrevonc.2007.06.014. Epub 2007 Aug 16. Crit Rev Oncol Hematol. 2008. PMID: 17702595 Clinical Trial.
Partial substitution of cisplatin with carboplatin in combination with etoposide in advanced non-small cell lung cancer (NSCLC): a multicentric randomised phase II trial.
Comella P, Frasci G, Panza N, De Cataldis G, Cioffi R, Curcio C, Nicolella D, Micillo E, Ianniello GP, Biondi E, Perchard J, Comella G. Comella P, et al. Among authors: frasci g. Lung Cancer. 1996 Aug;15(1):103-14. doi: 10.1016/0169-5002(96)00575-2. Lung Cancer. 1996. PMID: 8865128 Clinical Trial.
Cisplatin/carboplatin + etoposide + vinorelbine in advanced non-small-cell lung cancer: a multicentre randomised trial. Gruppo Oncologico Campano.
Comella P, Frasci G, De Cataldis G, Panza N, Cioffi R, Curcio C, Belli M, Bianco A, Ianniello G, Maiorino L, Della Vittoria M, Perchard J, Comella G. Comella P, et al. Among authors: frasci g. Br J Cancer. 1996 Dec;74(11):1805-11. doi: 10.1038/bjc.1996.634. Br J Cancer. 1996. PMID: 8956797 Free PMC article. Clinical Trial.
Cisplatin, gemcitabine, and vinorelbine combination therapy in advanced non-small-cell lung cancer: a phase II randomized study of the Southern Italy Cooperative Oncology Group.
Comella P, Frasci G, Panza N, Manzione L, Lorusso V, Di Rienzo G, Cioffi R, De Cataldis G, Maiorino L, Bilancia D, Nicolella G, Natale M, Carpagnano F, Pacilio C, De Lena M, Bianco A, Comella G. Comella P, et al. Among authors: frasci g. J Clin Oncol. 1999 May;17(5):1526-34. doi: 10.1200/JCO.1999.17.5.1526. J Clin Oncol. 1999. PMID: 10334540 Clinical Trial.
77 results